HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N-(p-methylphenylsulfonyl)phenoxazine

structure in first source

Also Known As:

PSB-12062

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Oxazines: 9
    - N-(p-methylphenylsulfonyl)phenoxazine: 1
Organic Chemicals: 133
- Amides: 2428
  - Sulfonamides: 2809
    - N-(p-methylphenylsulfonyl)phenoxazine: 1
- Sulfur Compounds: 278
  - Sulfones: 534
    - Sulfonamides: 2809
      - N-(p-methylphenylsulfonyl)phenoxazine: 1

Experts

1.	Ji, Rihui: 1 article (01/2021)
2.	Jiang, Xin: 1 article (01/2021)
3.	Xiang, Zhenghua: 1 article (01/2021)
4.	Yuan, Hongbin: 1 article (01/2021)

Related Diseases

1.	Reperfusion Injury 01/01/2021 - "Intraventricular injection of the P2X4 receptor antagonist 5-(3-bromophenyl)-1,3-dihydro-2H-benzofuro[3,2-e]-1,4-diazepin-2-one (5-BDBD) and PSB-12062 can partially block neuronal apoptosis, to promote the survival of neurons, indicating that ATP through P2X4 receptors is involved in the process of cerebral ischemia-reperfusion injury. "
2.	Brain Ischemia (Cerebral Ischemia) 01/01/2021 - "Intraventricular injection of the P2X4 receptor antagonist 5-(3-bromophenyl)-1,3-dihydro-2H-benzofuro[3,2-e]-1,4-diazepin-2-one (5-BDBD) and PSB-12062 can partially block neuronal apoptosis, to promote the survival of neurons, indicating that ATP through P2X4 receptors is involved in the process of cerebral ischemia-reperfusion injury. "

Related Drugs and Biologics

1.	Purinergic P2X4 Receptors
2.	Adenosine Triphosphate (ATP)

Related Therapies and Procedures

1.	Intraventricular Injections